AbCellera Biologics Inc. (ABCL)
NASDAQ: ABCL
· Real-Time Price · USD
4.74
0.09 (1.94%)
At close: Sep 26, 2025, 3:59 PM
4.75
0.21%
After-hours: Sep 26, 2025, 07:57 PM EDT
AbCellera Biologics Revenue
AbCellera Biologics reported an annual revenue of $28.83M, reflecting a -24.17% growth. For the quarter ending June 30, 2025, AbCellera Biologics generated $17.08M in revenue.
Revenue (ttm)
28.83M
Revenue Growth
-24.17%
Price / Sales Ratio
29.91
Revenue / Employee
48.38K
Employees
596
Market Cap
1.42B
Revenue Chart
History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 28.83M | -24.17% |
| Dec 31, 2023 | 38.02M | -92.17% |
| Dec 31, 2022 | 485.42M | +29.38% |
| Dec 31, 2021 | 375.2M | +60.92% |
| Dec 31, 2020 | 233.16M | +1907.96% |
| Dec 31, 2019 | 11.61M | +31.49% |
| Dec 31, 2018 | 8.83M | n/a |